info@synchemia.com | sales@synchemia.com 
9766925136 | 72 
N-Nitroso Enzalutamide Impurity 1
.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Enzalutamide is used to treat castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone), and metastatic castration-sensitive prostate cancer (prostate cancer that has spread to other parts of the body and responds to a hormone therapy or surgical.N-Nitroso Enzalutamide Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Enzalutamide Impurity 1 CAS NO:NA chemically represented as N-(4-Cyano-3-(trifluoromethyl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Enzalutamide Impurity 1.We supply N-Nitroso Enzalutamide Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142836 |
| CAS No | NA |
| Mol.F. | C18H26N3O7PS |
| Mol.Wt. | 459.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142837 |
| CAS No | NA |
| Mol.F. | C22H26N4O9S |
| Mol.Wt. | 522.53 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142838 |
| CAS No | NA |
| Mol.F. | C12H13N3O4 |
| Mol.Wt. | 263.25 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142839 |
| CAS No | NA |
| Mol.F. | C22H25N3O4S |
| Mol.Wt. | 427.52 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142840 |
| CAS No | NA |
| Mol.F. | C22H25N3O3S |
| Mol.Wt. | 411.52 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142841 |
| CAS No | NA |
| Mol.F. | C14H16BrN3O |
| Mol.Wt. | 322.21g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142842 |
| CAS No | NA |
| Mol.F. | C44H47N5O5S2 |
| Mol.Wt. | 790.01g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142843 |
| CAS No | NA |
| Mol.F. | C44H49N5O5S2 |
| Mol.Wt. | 792.03 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142844 |
| CAS No | NA |
| Mol.F. | C14H17N2O |
| Mol.Wt. | 243.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142845 |
| CAS No | NA |
| Mol.F. | C16H14N2O3S |
| Mol.Wt. | 314.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142846 |
| CAS No | NA |
| Mol.F. | C23H23N3O4 |
| Mol.Wt. | 405.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142847 |
| CAS No | NA |
| Mol.F. | C16H21N3O |
| Mol.Wt. | 271.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142848 |
| CAS No | NA |
| Mol.F. | C25H22N6O4 |
| Mol.Wt. | 470.49g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142849 |
| CAS No | NA |
| Mol.F. | C14H26N2O12 |
| Mol.Wt. | 414.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142850 |
| CAS No | NA |
| Mol.F. | C26H23N5O5 |
| Mol.Wt. | 485.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142851 |
| CAS No | NA |
| Mol.F. | C31H29N5O11 |
| Mol.Wt. | 647.60 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
